Next Article in Journal
Association between Oral Hygiene and Metabolic Syndrome: A Systematic Review and Meta-Analysis
Next Article in Special Issue
Decoding the Myeloid-Derived Suppressor Cells in Lymphoid Malignancies
Previous Article in Journal
Association between Add-On Dipeptidyl Peptidase-4 Inhibitor Therapy and Diabetic Retinopathy Progression
Previous Article in Special Issue
Myeloid-Derived Suppressor Cells and Mesenchymal Stem/Stromal Cells in Myeloid Malignancies
Review

MDSC in Mice and Men: Mechanisms of Immunosuppression in Cancer

1
De Duve Institute, Université Catholique de Louvain, Avenue Hippocrate 74, 1200 Brussels, Belgium
2
WELBIO, Avenue Hippocrate 74, 1200 Brussels, Belgium
*
Authors to whom correspondence should be addressed.
Academic Editor: Helen A. Papadaki
J. Clin. Med. 2021, 10(13), 2872; https://doi.org/10.3390/jcm10132872
Received: 11 May 2021 / Revised: 16 June 2021 / Accepted: 18 June 2021 / Published: 28 June 2021
(This article belongs to the Special Issue Myeloid-Derived Suppressor Cells (MDSCs) in Haematology)
Myeloid-derived suppressor cells (MDSCs) expand during pathological conditions in both humans and mice and their presence is linked to poor clinical outcomes for cancer patients. Studying MDSC immunosuppression is restricted by MDSCs’ rarity, short lifespan, heterogeneity, poor viability after freezing and the lack of MDSC-specific markers. In this review, we will compare identification and isolation strategies for human and murine MDSCs. We will also assess what direct and indirect immunosuppressive mechanisms have been attributed to MDSCs. While some immunosuppressive mechanisms are well-documented in mice, e.g., generation of ROS, direct evidence is still lacking in humans. In future, bulk or single-cell genomics could elucidate which phenotypic and functional phenotypes MDSCs adopt in particular microenvironments and help to identify potential targets for therapy. View Full-Text
Keywords: MDSCs; myeloid-derived suppressor cells; T-cells; human; mouse; immunosuppressive assays; cancer biology; immunotherapy MDSCs; myeloid-derived suppressor cells; T-cells; human; mouse; immunosuppressive assays; cancer biology; immunotherapy
Show Figures

Figure 1

MDPI and ACS Style

Vanhaver, C.; van der Bruggen, P.; Bruger, A.M. MDSC in Mice and Men: Mechanisms of Immunosuppression in Cancer. J. Clin. Med. 2021, 10, 2872. https://doi.org/10.3390/jcm10132872

AMA Style

Vanhaver C, van der Bruggen P, Bruger AM. MDSC in Mice and Men: Mechanisms of Immunosuppression in Cancer. Journal of Clinical Medicine. 2021; 10(13):2872. https://doi.org/10.3390/jcm10132872

Chicago/Turabian Style

Vanhaver, Christophe, Pierre van der Bruggen, and Annika M. Bruger. 2021. "MDSC in Mice and Men: Mechanisms of Immunosuppression in Cancer" Journal of Clinical Medicine 10, no. 13: 2872. https://doi.org/10.3390/jcm10132872

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop